Chemical romance: Here’s a little-known sector of the ASX that’s up 22 per cent in 2019

Clinical OMICsCancer Diagnostics: Droplet Digital PCR Testing for HPV+ Cancer in the Clinic

Endpoints NewsHealth groups say HHS is trying to 'rush reinstatement' of ACIP

Endpoints NewsB cell therapy maker Be Bio stops hemophilia trial

Clinical OMICsFibroblast Signaling Pathways Linked to Angiogenesis Differences in NSCLC

Endpoints NewsFDA raises no major red flags with Moderna's flu shot

FierceBiotechEli Lilly’s M&A spree continues with acquisition of non-opioid pain drugmaker 4E

FierceBiotechAmenable FDA review bodes well for Moderna's mRNA flu shot ahead of adcomm grilling

Clinical OMICsMini Brains Help Identify Treatment for Rare Form Parkinson’s Disease

Endpoints NewsFDA greenlights Colorado's drug import proposal

CellThe critical role of the endogenous immune compartment after CAR T cell therapy in recurrent GBM

FierceBiotechPE firm Altaris scoops up AI drug development outfit Simulations Plus for $375M

BioPharma DiveLilly buys non-opioid pain drugmaker 4E